Enhanced dissolution of valsartan-vanillin binary co-amorphous system loaded in mesoporous silica particles

被引:14
作者
Ali, Khan Hashim [1 ]
Ansari, Muhammad Mohsin [1 ]
Shah, Fawad Ali [1 ]
Din, Fakhar Ud [2 ]
Basit, Muhammad Abdul [3 ]
Kim, Jin-Ki [4 ]
Zeb, Alam [1 ]
机构
[1] Riphah Int Univ, Riphah Inst Pharmaceut Sci, Sector G-7-4,7th Ave, Islamabad 44000, Pakistan
[2] Quaid I Azam Univ, Dept Pharm, Islamabad, Pakistan
[3] Inst Space Technol, Dept Mat Sci & Engn, Islamabad, Pakistan
[4] Hanyang Univ, Inst Pharmaceut Sci & Technol, Coll Pharm, 55 Hanyangdaehak Ro, Ansan 15588, Gyeonggi, South Korea
关键词
Valsartan; vanillin; co-amorphous system; mesoporous silica particles; dissolution; PHYSICAL STABILITY; SOLUBLE DRUGS; AMINO-ACIDS; PHYSICOCHEMICAL PROPERTIES; COAMORPHOUS ATORVASTATIN; SOLUBILITY; DELIVERY; BIOAVAILABILITY; OPTIMIZATION; INDOMETHACIN;
D O I
10.1080/02652048.2019.1579265
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The study was aimed to prepare a co-amorphous system of valsartan (VAL) with vanillin (VAN) for improving its solubility and dissolution followed by its confinement in mesoporous silica particles (MSPs) to stabilise the co-amorphous system and prevent its recrystallization. Amorphous VAL and VAN were obtained through quench-cooling and VAL/VAN binary co-amorphous system (VAL/VAN-CAS) was prepared through solvent evaporation technique. The particle size and morphology of VAL/VAN-CAS-MSPs were studied using scanning electron microscopy (SEM) and solid-state characterisation was performed by differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD). The in vitro dissolution was investigated by dialysis bag diffusion method. SEM analysis revealed irregular shaped VAL/VAN-CAS-MSPs with a size range of 5-25m, while outcomes of DSC and XRPD confirmed the formation of VAL/VAN-CAS. The in vitro dissolution profiles demonstrated a significantly increased dissolution in first 60minutes from VAL/VAN-CAS (approximate to 68%) and VAL/VAN-CAS-MSPs (approximate to 76%) compared to powder VAL (approximate to 25%).
引用
收藏
页码:10 / 20
页数:11
相关论文
共 55 条
  • [21] What is a suitable dissolution method for drug nanoparticles?
    Heng, Desmond
    Cutler, David J.
    Chan, Hak-Kim
    Yun, Jimmy
    Raper, Judy A.
    [J]. PHARMACEUTICAL RESEARCH, 2008, 25 (07) : 1696 - 1701
  • [22] Mesoporous silica-based nanoplatforms for the delivery of photodynamic therapy agents
    Hong S.H.
    Choi Y.
    [J]. Journal of Pharmaceutical Investigation, 2018, 48 (1) : 3 - 17
  • [23] Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan
    Huang, Ying
    Zhang, Qi
    Wang, Jian-Rong
    Lin, Kai-Lei
    Mei, Xuefeng
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2017, 22 (01) : 69 - 76
  • [24] Kalam MA., 2007, CJPharmSci, V1, P30
  • [25] Curcumin drug delivery by vanillin-chitosan coated with calcium ferrite hybrid nanoparticles as carrier
    Kamaraj, Sriram
    Palanisamy, Uma Maheswari
    Mohamed, Meera Sheriffa Begum Kadhar
    Arthanareeswaran, Gangasalam
    Maria, Gover Antoniraj
    Kandasamy, Ruckmani
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 116 : 48 - 60
  • [26] Co-Amorphous Solid Dispersions for Solubility and Absorption Improvement of Drugs: Composition, Preparation, Characterization and Formulations for Oral Delivery
    Karagianni, Anna
    Kachrimanis, Kyriakos
    Nikolakakis, Ioannis
    [J]. PHARMACEUTICS, 2018, 10 (03):
  • [27] Kaza R., 2013, PHARM LETT, V5, P126
  • [28] Amino Acids as Co-amorphous Excipients for Simvastatin and Glibenclamide: Physical Properties and Stability
    Laitinen, Riikka
    Lobmann, Korbinian
    Grohganz, Holger
    Strachan, Clare
    Rades, Thomas
    [J]. MOLECULAR PHARMACEUTICS, 2014, 11 (07) : 2381 - 2389
  • [29] Angiotensin II type 1 receptor blockade with 80 and 160 mg valsartan in healthy, normotensive subjects
    Latif, F
    Tandon, S
    Obeleniene, R
    Hankins, SR
    Berlowitz, MS
    Ennezat, PV
    Le Jemtel, TH
    [J]. JOURNAL OF CARDIAC FAILURE, 2001, 7 (03) : 265 - 268
  • [30] Solubility of Valsartan in Different Organic Solvents and Ethanol plus Water Binary Mixtures from (278.15 to 313.15) K
    Liu, Yan
    Wang, Jingkang
    Wang, Xiaobo
    Liu, Peng
    Pang, Fei
    [J]. JOURNAL OF CHEMICAL AND ENGINEERING DATA, 2009, 54 (03) : 986 - 988